Leptin and Its Derivatives: A Potential Target for Autoimmune Diseases

(E-pub Ahead of Print)

Author(s): Han Han, Weiqiang Zhou*.

Journal Name: Current Drug Targets

Become EABM
Become Reviewer

Abstract:

Leptin is an adipocyte-derived hormone and product of the obese (ob) gene. The role of leptin as an immunomodulator in inflammatory and immune responses has attracted increasing attention in recent years. Leptin plays an important regulatory role as an immunomodulatory factor in the maintenance of immune function and homeostasis. It mostly affects responses through the immunomodulation of monocytes, dendritic cells, neutrophils, NK cells, dendritic cells, T and B cell development and functions. Leptin is also an important inflammatory regulator, wherein higher levels influence the secretion rates of IL-6, C-reactive protein, and TNF-α. Meanwhile, leptin is highly involved in processes related to human metabolism, inflammatory reactions, cellular development, and diseases including hematopoiesis and others. Therefore, in respect of its diverse functions in immunity, leptin has been explored as a potential target for therapeutic development in treating autoimmune diseases.

Keywords: leptin, immune response, autoimmune diseases, hematopoiesis, inflammatory reactions

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1389450120666190729120557
Price: $95

Article Metrics

PDF: 2